Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line comb
about
Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utilityPredicting aortic enlargement in type B aortic dissectionA combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention.Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis.The combination of amlodipine and angiotensin receptor blocker or diuretics in high-risk hypertensive patients: rationale, design and baseline characteristics.Aliskiren in hypertension: evidence for its potential therapeutic valueEffective management of hypertension with dihydropyridine calcium channel blocker-based combination therapy in patients at high cardiovascular riskFixed combinations in the management of hypertension: patient perspectives and rationale for development and utility of the olmesartan-amlodipine combinationExpedited blood pressure control with initial angiotensin II antagonist/diuretic therapy compared with stepped-care therapy in patients with ambulatory systolic hypertension.Amlodipine and valsartan as components of a rational and effective fixed-dose combination.Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertensionI brazilian position paper on antihypertensive drug combinationAmerican College Of Endocrinology Pre-Diabetes Consensus Conference: part one.Methods of Blood Pressure Assessment Used in Milestone Hypertension Trials
P2860
Q33571219-D237D2FC-AE75-48EF-9C8C-FEF1219D3E61Q33737063-CE8DE20A-8A4B-4313-9D8D-D8D22CC555D5Q34018990-882DDD18-2B31-4AE2-AFB5-4CF1E9C084F2Q34380070-4CB4CA91-DD96-4175-88A0-1D87287BA2D5Q34699614-290C150B-B753-40C2-9A65-268DA43525A1Q35876368-EF8E845E-82FE-4AE8-8726-36F7745099A9Q36572955-3F6AD25A-07C6-46BC-B78F-585FF89B7F71Q36835866-47734DC3-AB8E-4DC1-9FB2-D51D0D3BA4AFQ37112415-04C13A45-DF46-4B61-A8C9-0DA0045F280DQ37167534-D547A367-6C6B-4764-A1CE-37E35B1ECB82Q37167560-AB58C9BE-B729-4E1E-830D-473D6223EA16Q37703801-7DA81114-D81E-4577-9226-53402DA977BEQ42918336-58B3F7FC-06DC-44BE-A521-6901526266D8Q57142821-AD13D437-26DB-43E1-A686-7093D07D98C1
P2860
Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line comb
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Rationale and design of the av ...... ome effects of first-line comb
@ast
Rationale and design of the av ...... ome effects of first-line comb
@en
type
label
Rationale and design of the av ...... ome effects of first-line comb
@ast
Rationale and design of the av ...... ome effects of first-line comb
@en
prefLabel
Rationale and design of the av ...... ome effects of first-line comb
@ast
Rationale and design of the av ...... ome effects of first-line comb
@en
P2093
P1476
Rationale and design of the av ...... ome effects of first-line comb
@en
P2093
Chuan-Chuan Wun
Eric J Velazquez
George L Bakris
Kenneth A Jamerson
Martin Lefkowitz
Michael A Weber
Sheryl Manfreda
P304
P356
10.1016/J.AMJHYPER.2004.05.004
P577
2004-09-01T00:00:00Z